Directors Trey PowersByron PickardChandrika ViraWilliam MillikenAnna Phillips, and Tyler Dutton were mentioned as representing TwinStrand Biosciences in the Reuters article “Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says.” Following is an excerpt from the article:

“Precision oncology company Guardant Health (GH.O) was hit with an $83.4 million verdict by a jury in Delaware federal court, which found that its cancer-testing kits violate the patent rights of biotech company TwinStrand Biosciences and the University of Washington.

The jury said on Tuesday that Guardant’s genetic-sequencing technology infringes two patents and that the infringement was willful, which could lead to the award being multiplied.”

© 2023 Reuters. All rights reserved